0.1M Tris, 0.1M Glycine, 10% Glycerol (pH7). 0.01% Thimerosal was added as a preservative.
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
1 mg/ml (Please refer to the vial label for the specific concentration.)
Recombinant protein encompassing a sequence within the center region of Human HLA-DR beta. The exact sequence is proprietary.
Purified by antigen-affinity chromatography.
For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
major histocompatibility complex, class II, DR beta 1 , major histocompatibility complex, class II, DR beta 3 , major histocompatibility complex, class II, DR beta 4 , major histocompatibility complex, class II, DR beta 5 , DRB1 , HLA-DR1B , HLA-DRB , SS1 , DRB3 , HLA-DPB1 , HLA-DR1B , HLA-DR3B , DR4 , DRB4 , HLA-DR4B
Cell membrane,Endoplasmic reticulum membrane,Endosome membrane,Lysosome membrane,Cell membrane; Single-pass type I membrane protein